nodes	percent_of_prediction	percent_of_DWPC	metapath
Ivacaftor—CYP3A4—prostate cancer	0.168	1	CbGaD
Ivacaftor—ORM1—Abiraterone—prostate cancer	0.117	0.211	CbGbCtD
Ivacaftor—ALB—Abiraterone—prostate cancer	0.0491	0.0886	CbGbCtD
Ivacaftor—CFTR—vas deferens—prostate cancer	0.0419	0.517	CbGeAlD
Ivacaftor—ALB—Estrone—prostate cancer	0.0355	0.064	CbGbCtD
Ivacaftor—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0353	0.0638	CbGbCtD
Ivacaftor—ABCB1—Estramustine—prostate cancer	0.0288	0.052	CbGbCtD
Ivacaftor—ALB—Estradiol—prostate cancer	0.0204	0.0368	CbGbCtD
Ivacaftor—ABCB1—Cabazitaxel—prostate cancer	0.019	0.0343	CbGbCtD
Ivacaftor—CYP3A4—Bicalutamide—prostate cancer	0.0186	0.0335	CbGbCtD
Ivacaftor—ABCB1—Estrone—prostate cancer	0.0186	0.0335	CbGbCtD
Ivacaftor—ALB—Prednisone—prostate cancer	0.0175	0.0316	CbGbCtD
Ivacaftor—CYP3A4—Estramustine—prostate cancer	0.0173	0.0311	CbGbCtD
Ivacaftor—ABCB1—Ethinyl Estradiol—prostate cancer	0.0165	0.0299	CbGbCtD
Ivacaftor—CYP3A4—Abiraterone—prostate cancer	0.0154	0.0278	CbGbCtD
Ivacaftor—CYP3A4—Flutamide—prostate cancer	0.0154	0.0278	CbGbCtD
Ivacaftor—CFTR—semen—prostate cancer	0.0149	0.184	CbGeAlD
Ivacaftor—ABCB1—Conjugated Estrogens—prostate cancer	0.0121	0.0219	CbGbCtD
Ivacaftor—CYP3A4—Cabazitaxel—prostate cancer	0.0114	0.0205	CbGbCtD
Ivacaftor—CYP3A4—Estrone—prostate cancer	0.0111	0.0201	CbGbCtD
Ivacaftor—ABCB1—Mitoxantrone—prostate cancer	0.011	0.0199	CbGbCtD
Ivacaftor—ABCB1—Estradiol—prostate cancer	0.0107	0.0192	CbGbCtD
Ivacaftor—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00991	0.0179	CbGbCtD
Ivacaftor—ABCB1—Prednisone—prostate cancer	0.00916	0.0165	CbGbCtD
Ivacaftor—CYP3A4—Conjugated Estrogens—prostate cancer	0.00727	0.0131	CbGbCtD
Ivacaftor—ABCB1—Etoposide—prostate cancer	0.00696	0.0126	CbGbCtD
Ivacaftor—CYP3A4—Mitoxantrone—prostate cancer	0.00661	0.0119	CbGbCtD
Ivacaftor—CYP3A4—Estradiol—prostate cancer	0.00639	0.0115	CbGbCtD
Ivacaftor—ABCB1—Docetaxel—prostate cancer	0.00637	0.0115	CbGbCtD
Ivacaftor—CYP3A4—Prednisone—prostate cancer	0.00549	0.00991	CbGbCtD
Ivacaftor—ABCB1—Doxorubicin—prostate cancer	0.00475	0.00857	CbGbCtD
Ivacaftor—CYP3A4—Etoposide—prostate cancer	0.00417	0.00753	CbGbCtD
Ivacaftor—CYP3A4—Docetaxel—prostate cancer	0.00381	0.00689	CbGbCtD
Ivacaftor—CFTR—prostate gland—prostate cancer	0.00374	0.0461	CbGeAlD
Ivacaftor—CFTR—seminal vesicle—prostate cancer	0.00317	0.039	CbGeAlD
Ivacaftor—CYP3A4—Doxorubicin—prostate cancer	0.00284	0.00513	CbGbCtD
Ivacaftor—CFTR—epithelium—prostate cancer	0.00275	0.0339	CbGeAlD
Ivacaftor—CFTR—renal system—prostate cancer	0.00255	0.0314	CbGeAlD
Ivacaftor—CYP3A4—urine—prostate cancer	0.00221	0.0272	CbGeAlD
Ivacaftor—ORM1—prostate gland—prostate cancer	0.0019	0.0234	CbGeAlD
Ivacaftor—CFTR—testis—prostate cancer	0.00165	0.0203	CbGeAlD
Ivacaftor—ORM1—bone marrow—prostate cancer	0.000979	0.0121	CbGeAlD
Ivacaftor—ALB—testis—prostate cancer	0.000734	0.00905	CbGeAlD
Ivacaftor—ORM1—lymph node—prostate cancer	0.000607	0.00748	CbGeAlD
Ivacaftor—ABCB1—prostate gland—prostate cancer	0.000561	0.00692	CbGeAlD
Ivacaftor—CYP3A4—renal system—prostate cancer	0.000541	0.00666	CbGeAlD
Ivacaftor—ALB—lymph node—prostate cancer	0.000532	0.00656	CbGeAlD
Ivacaftor—ABCB1—seminal vesicle—prostate cancer	0.000475	0.00585	CbGeAlD
Ivacaftor—ABCB1—epithelium—prostate cancer	0.000412	0.00509	CbGeAlD
Ivacaftor—ABCB1—renal system—prostate cancer	0.000383	0.00472	CbGeAlD
Ivacaftor—ABCB1—urethra—prostate cancer	0.000376	0.00463	CbGeAlD
Ivacaftor—ABCB1—bone marrow—prostate cancer	0.000289	0.00357	CbGeAlD
Ivacaftor—Dermatitis—Nilutamide—prostate cancer	0.000276	0.00185	CcSEcCtD
Ivacaftor—Rash—Flutamide—prostate cancer	0.000275	0.00184	CcSEcCtD
Ivacaftor—Dermatitis—Flutamide—prostate cancer	0.000274	0.00184	CcSEcCtD
Ivacaftor—Headache—Nilutamide—prostate cancer	0.000274	0.00184	CcSEcCtD
Ivacaftor—Infestation NOS—Estradiol—prostate cancer	0.000273	0.00183	CcSEcCtD
Ivacaftor—Infestation—Estradiol—prostate cancer	0.000273	0.00183	CcSEcCtD
Ivacaftor—Headache—Flutamide—prostate cancer	0.000273	0.00183	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Bicalutamide—prostate cancer	0.000273	0.00183	CcSEcCtD
Ivacaftor—Dizziness—Estradiol valerate/Dienogest—prostate cancer	0.000272	0.00182	CcSEcCtD
Ivacaftor—Hyperaesthesia—Epirubicin—prostate cancer	0.00027	0.00181	CcSEcCtD
Ivacaftor—Diarrhoea—Degarelix—prostate cancer	0.000267	0.00179	CcSEcCtD
Ivacaftor—Upper respiratory tract infection—Mitoxantrone—prostate cancer	0.000265	0.00178	CcSEcCtD
Ivacaftor—Infection—Ethinyl Estradiol—prostate cancer	0.000265	0.00178	CcSEcCtD
Ivacaftor—Nervous system disorder—Ethinyl Estradiol—prostate cancer	0.000262	0.00175	CcSEcCtD
Ivacaftor—Nausea—Nilutamide—prostate cancer	0.00026	0.00174	CcSEcCtD
Ivacaftor—Skin disorder—Ethinyl Estradiol—prostate cancer	0.000259	0.00174	CcSEcCtD
Ivacaftor—Rash—Estradiol valerate/Dienogest—prostate cancer	0.000259	0.00174	CcSEcCtD
Ivacaftor—Ear pain—Capecitabine—prostate cancer	0.000259	0.00174	CcSEcCtD
Ivacaftor—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	0.000259	0.00174	CcSEcCtD
Ivacaftor—Nausea—Flutamide—prostate cancer	0.000259	0.00173	CcSEcCtD
Ivacaftor—Dizziness—Degarelix—prostate cancer	0.000258	0.00173	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Bicalutamide—prostate cancer	0.000258	0.00173	CcSEcCtD
Ivacaftor—Headache—Estradiol valerate/Dienogest—prostate cancer	0.000257	0.00173	CcSEcCtD
Ivacaftor—Diarrhoea—Cabazitaxel—prostate cancer	0.000252	0.00169	CcSEcCtD
Ivacaftor—Hyperaesthesia—Doxorubicin—prostate cancer	0.00025	0.00168	CcSEcCtD
Ivacaftor—Abdominal pain—Bicalutamide—prostate cancer	0.00025	0.00167	CcSEcCtD
Ivacaftor—ABCB1—testis—prostate cancer	0.000247	0.00305	CbGeAlD
Ivacaftor—Rash—Degarelix—prostate cancer	0.000246	0.00165	CcSEcCtD
Ivacaftor—Dermatitis—Degarelix—prostate cancer	0.000246	0.00165	CcSEcCtD
Ivacaftor—Rhinitis—Estradiol—prostate cancer	0.000246	0.00165	CcSEcCtD
Ivacaftor—Headache—Degarelix—prostate cancer	0.000245	0.00164	CcSEcCtD
Ivacaftor—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.000244	0.00164	CcSEcCtD
Ivacaftor—Dizziness—Cabazitaxel—prostate cancer	0.000243	0.00163	CcSEcCtD
Ivacaftor—Connective tissue disorder—Estradiol—prostate cancer	0.000241	0.00161	CcSEcCtD
Ivacaftor—Nausea—Degarelix—prostate cancer	0.000232	0.00156	CcSEcCtD
Ivacaftor—Headache—Cabazitaxel—prostate cancer	0.000231	0.00155	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Ethinyl Estradiol—prostate cancer	0.00023	0.00154	CcSEcCtD
Ivacaftor—Arthralgia—Goserelin—prostate cancer	0.000229	0.00154	CcSEcCtD
Ivacaftor—Myalgia—Goserelin—prostate cancer	0.000229	0.00154	CcSEcCtD
Ivacaftor—Rhinitis—Mitoxantrone—prostate cancer	0.000229	0.00153	CcSEcCtD
Ivacaftor—Tinnitus—Estradiol—prostate cancer	0.000229	0.00153	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Goserelin—prostate cancer	0.000228	0.00153	CcSEcCtD
Ivacaftor—Arthralgia—Conjugated Estrogens—prostate cancer	0.000227	0.00152	CcSEcCtD
Ivacaftor—Myalgia—Conjugated Estrogens—prostate cancer	0.000227	0.00152	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—prostate cancer	0.000225	0.00151	CcSEcCtD
Ivacaftor—Blood bilirubin increased—Epirubicin—prostate cancer	0.000224	0.0015	CcSEcCtD
Ivacaftor—Mediastinal disorder—Estradiol—prostate cancer	0.000221	0.00148	CcSEcCtD
Ivacaftor—Nausea—Cabazitaxel—prostate cancer	0.000219	0.00147	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Ethinyl Estradiol—prostate cancer	0.000218	0.00146	CcSEcCtD
Ivacaftor—Infection—Goserelin—prostate cancer	0.000218	0.00146	CcSEcCtD
Ivacaftor—Infection—Conjugated Estrogens—prostate cancer	0.000216	0.00145	CcSEcCtD
Ivacaftor—Diarrhoea—Bicalutamide—prostate cancer	0.000216	0.00145	CcSEcCtD
Ivacaftor—Nervous system disorder—Goserelin—prostate cancer	0.000215	0.00144	CcSEcCtD
Ivacaftor—Nervous system disorder—Conjugated Estrogens—prostate cancer	0.000213	0.00143	CcSEcCtD
Ivacaftor—Skin disorder—Goserelin—prostate cancer	0.000213	0.00143	CcSEcCtD
Ivacaftor—Infestation NOS—Etoposide—prostate cancer	0.000212	0.00142	CcSEcCtD
Ivacaftor—Infestation—Etoposide—prostate cancer	0.000212	0.00142	CcSEcCtD
Ivacaftor—Skin disorder—Conjugated Estrogens—prostate cancer	0.000211	0.00142	CcSEcCtD
Ivacaftor—Abdominal pain—Ethinyl Estradiol—prostate cancer	0.000211	0.00141	CcSEcCtD
Ivacaftor—Dizziness—Bicalutamide—prostate cancer	0.000209	0.0014	CcSEcCtD
Ivacaftor—Blood bilirubin increased—Doxorubicin—prostate cancer	0.000207	0.00139	CcSEcCtD
Ivacaftor—Breast disorder—Docetaxel—prostate cancer	0.000206	0.00138	CcSEcCtD
Ivacaftor—Aspartate aminotransferase increased—Docetaxel—prostate cancer	0.000206	0.00138	CcSEcCtD
Ivacaftor—Nasopharyngitis—Docetaxel—prostate cancer	0.000204	0.00137	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Goserelin—prostate cancer	0.0002	0.00134	CcSEcCtD
Ivacaftor—Breast disorder—Capecitabine—prostate cancer	0.0002	0.00134	CcSEcCtD
Ivacaftor—Rash—Bicalutamide—prostate cancer	0.000199	0.00133	CcSEcCtD
Ivacaftor—Aspartate aminotransferase increased—Capecitabine—prostate cancer	0.000199	0.00133	CcSEcCtD
Ivacaftor—Dermatitis—Bicalutamide—prostate cancer	0.000199	0.00133	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Conjugated Estrogens—prostate cancer	0.000198	0.00133	CcSEcCtD
Ivacaftor—Headache—Bicalutamide—prostate cancer	0.000198	0.00133	CcSEcCtD
Ivacaftor—Nasopharyngitis—Capecitabine—prostate cancer	0.000198	0.00132	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Conjugated Estrogens—prostate cancer	0.000188	0.00126	CcSEcCtD
Ivacaftor—Nausea—Bicalutamide—prostate cancer	0.000188	0.00126	CcSEcCtD
Ivacaftor—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.000183	0.00122	CcSEcCtD
Ivacaftor—Arthralgia—Estradiol—prostate cancer	0.000182	0.00122	CcSEcCtD
Ivacaftor—Myalgia—Estradiol—prostate cancer	0.000182	0.00122	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Estradiol—prostate cancer	0.00018	0.00121	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Goserelin—prostate cancer	0.00018	0.0012	CcSEcCtD
Ivacaftor—ABCB1—lymph node—prostate cancer	0.000179	0.00221	CbGeAlD
Ivacaftor—Gastrointestinal pain—Conjugated Estrogens—prostate cancer	0.000178	0.00119	CcSEcCtD
Ivacaftor—Upper respiratory tract infection—Capecitabine—prostate cancer	0.000177	0.00119	CcSEcCtD
Ivacaftor—Dizziness—Ethinyl Estradiol—prostate cancer	0.000177	0.00118	CcSEcCtD
Ivacaftor—Infestation NOS—Docetaxel—prostate cancer	0.000176	0.00118	CcSEcCtD
Ivacaftor—Infestation—Docetaxel—prostate cancer	0.000176	0.00118	CcSEcCtD
Ivacaftor—Abdominal pain—Goserelin—prostate cancer	0.000174	0.00116	CcSEcCtD
Ivacaftor—Infection—Estradiol—prostate cancer	0.000173	0.00116	CcSEcCtD
Ivacaftor—Abdominal pain—Conjugated Estrogens—prostate cancer	0.000172	0.00115	CcSEcCtD
Ivacaftor—Mediastinal disorder—Etoposide—prostate cancer	0.000171	0.00115	CcSEcCtD
Ivacaftor—Nervous system disorder—Estradiol—prostate cancer	0.000171	0.00114	CcSEcCtD
Ivacaftor—Infestation NOS—Capecitabine—prostate cancer	0.00017	0.00114	CcSEcCtD
Ivacaftor—Infestation—Capecitabine—prostate cancer	0.00017	0.00114	CcSEcCtD
Ivacaftor—Myalgia—Mitoxantrone—prostate cancer	0.000169	0.00113	CcSEcCtD
Ivacaftor—Arthralgia—Mitoxantrone—prostate cancer	0.000169	0.00113	CcSEcCtD
Ivacaftor—Skin disorder—Estradiol—prostate cancer	0.000169	0.00113	CcSEcCtD
Ivacaftor—Rash—Ethinyl Estradiol—prostate cancer	0.000168	0.00113	CcSEcCtD
Ivacaftor—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000168	0.00113	CcSEcCtD
Ivacaftor—Headache—Ethinyl Estradiol—prostate cancer	0.000167	0.00112	CcSEcCtD
Ivacaftor—Infection—Mitoxantrone—prostate cancer	0.000161	0.00108	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Estradiol—prostate cancer	0.000159	0.00106	CcSEcCtD
Ivacaftor—Nausea—Ethinyl Estradiol—prostate cancer	0.000159	0.00106	CcSEcCtD
Ivacaftor—Rhinitis—Docetaxel—prostate cancer	0.000158	0.00106	CcSEcCtD
Ivacaftor—Hypoglycaemia—Epirubicin—prostate cancer	0.000158	0.00106	CcSEcCtD
Ivacaftor—Skin disorder—Mitoxantrone—prostate cancer	0.000158	0.00106	CcSEcCtD
Ivacaftor—Connective tissue disorder—Docetaxel—prostate cancer	0.000155	0.00104	CcSEcCtD
Ivacaftor—Rhinitis—Capecitabine—prostate cancer	0.000153	0.00103	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Estradiol—prostate cancer	0.00015	0.00101	CcSEcCtD
Ivacaftor—Diarrhoea—Goserelin—prostate cancer	0.00015	0.00101	CcSEcCtD
Ivacaftor—Connective tissue disorder—Capecitabine—prostate cancer	0.00015	0.00101	CcSEcCtD
Ivacaftor—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000149	0.000998	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Mitoxantrone—prostate cancer	0.000148	0.000991	CcSEcCtD
Ivacaftor—Hypoglycaemia—Doxorubicin—prostate cancer	0.000146	0.000978	CcSEcCtD
Ivacaftor—Dizziness—Goserelin—prostate cancer	0.000145	0.000974	CcSEcCtD
Ivacaftor—Dizziness—Conjugated Estrogens—prostate cancer	0.000144	0.000965	CcSEcCtD
Ivacaftor—Tinnitus—Capecitabine—prostate cancer	0.000143	0.000955	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Estradiol—prostate cancer	0.000142	0.000955	CcSEcCtD
Ivacaftor—Mediastinal disorder—Docetaxel—prostate cancer	0.000142	0.000954	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Etoposide—prostate cancer	0.00014	0.000937	CcSEcCtD
Ivacaftor—Breast disorder—Epirubicin—prostate cancer	0.000139	0.000932	CcSEcCtD
Ivacaftor—Aspartate aminotransferase increased—Epirubicin—prostate cancer	0.000139	0.000929	CcSEcCtD
Ivacaftor—Rash—Goserelin—prostate cancer	0.000139	0.000928	CcSEcCtD
Ivacaftor—Dermatitis—Goserelin—prostate cancer	0.000138	0.000928	CcSEcCtD
Ivacaftor—Mediastinal disorder—Capecitabine—prostate cancer	0.000138	0.000923	CcSEcCtD
Ivacaftor—Abdominal pain—Estradiol—prostate cancer	0.000138	0.000923	CcSEcCtD
Ivacaftor—Nasopharyngitis—Epirubicin—prostate cancer	0.000138	0.000923	CcSEcCtD
Ivacaftor—Headache—Goserelin—prostate cancer	0.000138	0.000922	CcSEcCtD
Ivacaftor—Rash—Conjugated Estrogens—prostate cancer	0.000137	0.00092	CcSEcCtD
Ivacaftor—Dermatitis—Conjugated Estrogens—prostate cancer	0.000137	0.000919	CcSEcCtD
Ivacaftor—Headache—Conjugated Estrogens—prostate cancer	0.000136	0.000914	CcSEcCtD
Ivacaftor—Infection—Etoposide—prostate cancer	0.000134	0.000899	CcSEcCtD
Ivacaftor—Connective tissue disorder—Prednisone—prostate cancer	0.000134	0.000897	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Mitoxantrone—prostate cancer	0.000133	0.000889	CcSEcCtD
Ivacaftor—Skin disorder—Etoposide—prostate cancer	0.000131	0.000879	CcSEcCtD
Ivacaftor—Nausea—Goserelin—prostate cancer	0.00013	0.000875	CcSEcCtD
Ivacaftor—Nausea—Conjugated Estrogens—prostate cancer	0.000129	0.000866	CcSEcCtD
Ivacaftor—Breast disorder—Doxorubicin—prostate cancer	0.000129	0.000863	CcSEcCtD
Ivacaftor—Abdominal pain—Mitoxantrone—prostate cancer	0.000128	0.00086	CcSEcCtD
Ivacaftor—Aspartate aminotransferase increased—Doxorubicin—prostate cancer	0.000128	0.00086	CcSEcCtD
Ivacaftor—Nasopharyngitis—Doxorubicin—prostate cancer	0.000127	0.000854	CcSEcCtD
Ivacaftor—Upper respiratory tract infection—Epirubicin—prostate cancer	0.000124	0.000829	CcSEcCtD
Ivacaftor—Diarrhoea—Estradiol—prostate cancer	0.000119	0.000799	CcSEcCtD
Ivacaftor—Infestation NOS—Epirubicin—prostate cancer	0.000119	0.000795	CcSEcCtD
Ivacaftor—Infestation—Epirubicin—prostate cancer	0.000119	0.000795	CcSEcCtD
Ivacaftor—Arthralgia—Docetaxel—prostate cancer	0.000117	0.000784	CcSEcCtD
Ivacaftor—Myalgia—Docetaxel—prostate cancer	0.000117	0.000784	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Etoposide—prostate cancer	0.000117	0.000781	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	0.000116	0.000779	CcSEcCtD
Ivacaftor—Dizziness—Estradiol—prostate cancer	0.000115	0.000772	CcSEcCtD
Ivacaftor—Upper respiratory tract infection—Doxorubicin—prostate cancer	0.000114	0.000767	CcSEcCtD
Ivacaftor—Arthralgia—Capecitabine—prostate cancer	0.000113	0.000759	CcSEcCtD
Ivacaftor—Myalgia—Capecitabine—prostate cancer	0.000113	0.000759	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	0.000113	0.000754	CcSEcCtD
Ivacaftor—Infection—Docetaxel—prostate cancer	0.000111	0.000747	CcSEcCtD
Ivacaftor—Diarrhoea—Mitoxantrone—prostate cancer	0.000111	0.000744	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Etoposide—prostate cancer	0.00011	0.00074	CcSEcCtD
Ivacaftor—Nervous system disorder—Docetaxel—prostate cancer	0.00011	0.000737	CcSEcCtD
Ivacaftor—Rash—Estradiol—prostate cancer	0.00011	0.000736	CcSEcCtD
Ivacaftor—Infestation NOS—Doxorubicin—prostate cancer	0.00011	0.000736	CcSEcCtD
Ivacaftor—Infestation—Doxorubicin—prostate cancer	0.00011	0.000736	CcSEcCtD
Ivacaftor—Dermatitis—Estradiol—prostate cancer	0.00011	0.000735	CcSEcCtD
Ivacaftor—Headache—Estradiol—prostate cancer	0.000109	0.000731	CcSEcCtD
Ivacaftor—Skin disorder—Docetaxel—prostate cancer	0.000109	0.00073	CcSEcCtD
Ivacaftor—Infection—Capecitabine—prostate cancer	0.000108	0.000723	CcSEcCtD
Ivacaftor—Rhinitis—Epirubicin—prostate cancer	0.000107	0.000716	CcSEcCtD
Ivacaftor—Abdominal pain—Etoposide—prostate cancer	0.000107	0.000715	CcSEcCtD
Ivacaftor—Nervous system disorder—Capecitabine—prostate cancer	0.000107	0.000714	CcSEcCtD
Ivacaftor—Skin disorder—Capecitabine—prostate cancer	0.000105	0.000707	CcSEcCtD
Ivacaftor—Connective tissue disorder—Epirubicin—prostate cancer	0.000105	0.000701	CcSEcCtD
Ivacaftor—Nausea—Estradiol—prostate cancer	0.000103	0.000693	CcSEcCtD
Ivacaftor—Rash—Mitoxantrone—prostate cancer	0.000102	0.000686	CcSEcCtD
Ivacaftor—Dermatitis—Mitoxantrone—prostate cancer	0.000102	0.000685	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Docetaxel—prostate cancer	0.000102	0.000685	CcSEcCtD
Ivacaftor—Headache—Mitoxantrone—prostate cancer	0.000102	0.000681	CcSEcCtD
Ivacaftor—Arthralgia—Prednisone—prostate cancer	0.000101	0.000676	CcSEcCtD
Ivacaftor—Myalgia—Prednisone—prostate cancer	0.000101	0.000676	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	0.0001	0.000672	CcSEcCtD
Ivacaftor—Tinnitus—Epirubicin—prostate cancer	9.93e-05	0.000666	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Capecitabine—prostate cancer	9.89e-05	0.000663	CcSEcCtD
Ivacaftor—Rhinitis—Doxorubicin—prostate cancer	9.88e-05	0.000662	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Docetaxel—prostate cancer	9.68e-05	0.000649	CcSEcCtD
Ivacaftor—Connective tissue disorder—Doxorubicin—prostate cancer	9.68e-05	0.000649	CcSEcCtD
Ivacaftor—Nausea—Mitoxantrone—prostate cancer	9.64e-05	0.000646	CcSEcCtD
Ivacaftor—Infection—Prednisone—prostate cancer	9.61e-05	0.000644	CcSEcCtD
Ivacaftor—Mediastinal disorder—Epirubicin—prostate cancer	9.6e-05	0.000643	CcSEcCtD
Ivacaftor—Nervous system disorder—Prednisone—prostate cancer	9.49e-05	0.000636	CcSEcCtD
Ivacaftor—Skin disorder—Prednisone—prostate cancer	9.4e-05	0.00063	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Capecitabine—prostate cancer	9.38e-05	0.000628	CcSEcCtD
Ivacaftor—Diarrhoea—Etoposide—prostate cancer	9.24e-05	0.000619	CcSEcCtD
Ivacaftor—Tinnitus—Doxorubicin—prostate cancer	9.19e-05	0.000616	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Docetaxel—prostate cancer	9.17e-05	0.000615	CcSEcCtD
Ivacaftor—Dizziness—Etoposide—prostate cancer	8.93e-05	0.000598	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Capecitabine—prostate cancer	8.88e-05	0.000595	CcSEcCtD
Ivacaftor—Mediastinal disorder—Doxorubicin—prostate cancer	8.88e-05	0.000595	CcSEcCtD
Ivacaftor—Abdominal pain—Docetaxel—prostate cancer	8.87e-05	0.000594	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Prednisone—prostate cancer	8.81e-05	0.000591	CcSEcCtD
Ivacaftor—Abdominal pain—Capecitabine—prostate cancer	8.59e-05	0.000575	CcSEcCtD
Ivacaftor—Rash—Etoposide—prostate cancer	8.51e-05	0.00057	CcSEcCtD
Ivacaftor—Dermatitis—Etoposide—prostate cancer	8.5e-05	0.00057	CcSEcCtD
Ivacaftor—Headache—Etoposide—prostate cancer	8.46e-05	0.000567	CcSEcCtD
Ivacaftor—Nausea—Etoposide—prostate cancer	8.02e-05	0.000537	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Prednisone—prostate cancer	7.91e-05	0.00053	CcSEcCtD
Ivacaftor—Arthralgia—Epirubicin—prostate cancer	7.89e-05	0.000529	CcSEcCtD
Ivacaftor—Myalgia—Epirubicin—prostate cancer	7.89e-05	0.000529	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	7.84e-05	0.000525	CcSEcCtD
Ivacaftor—Diarrhoea—Docetaxel—prostate cancer	7.67e-05	0.000514	CcSEcCtD
Ivacaftor—Abdominal pain—Prednisone—prostate cancer	7.65e-05	0.000513	CcSEcCtD
Ivacaftor—Infection—Epirubicin—prostate cancer	7.52e-05	0.000504	CcSEcCtD
Ivacaftor—Diarrhoea—Capecitabine—prostate cancer	7.43e-05	0.000498	CcSEcCtD
Ivacaftor—Nervous system disorder—Epirubicin—prostate cancer	7.42e-05	0.000497	CcSEcCtD
Ivacaftor—Dizziness—Docetaxel—prostate cancer	7.42e-05	0.000497	CcSEcCtD
Ivacaftor—Skin disorder—Epirubicin—prostate cancer	7.35e-05	0.000493	CcSEcCtD
Ivacaftor—Myalgia—Doxorubicin—prostate cancer	7.3e-05	0.00049	CcSEcCtD
Ivacaftor—Arthralgia—Doxorubicin—prostate cancer	7.3e-05	0.00049	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	7.25e-05	0.000486	CcSEcCtD
Ivacaftor—Dizziness—Capecitabine—prostate cancer	7.18e-05	0.000481	CcSEcCtD
Ivacaftor—Rash—Docetaxel—prostate cancer	7.07e-05	0.000474	CcSEcCtD
Ivacaftor—Dermatitis—Docetaxel—prostate cancer	7.07e-05	0.000474	CcSEcCtD
Ivacaftor—Headache—Docetaxel—prostate cancer	7.03e-05	0.000471	CcSEcCtD
Ivacaftor—Infection—Doxorubicin—prostate cancer	6.95e-05	0.000466	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Epirubicin—prostate cancer	6.89e-05	0.000462	CcSEcCtD
Ivacaftor—Nervous system disorder—Doxorubicin—prostate cancer	6.87e-05	0.00046	CcSEcCtD
Ivacaftor—Rash—Capecitabine—prostate cancer	6.85e-05	0.000459	CcSEcCtD
Ivacaftor—Dermatitis—Capecitabine—prostate cancer	6.84e-05	0.000459	CcSEcCtD
Ivacaftor—Headache—Capecitabine—prostate cancer	6.8e-05	0.000456	CcSEcCtD
Ivacaftor—Skin disorder—Doxorubicin—prostate cancer	6.8e-05	0.000456	CcSEcCtD
Ivacaftor—Nausea—Docetaxel—prostate cancer	6.66e-05	0.000447	CcSEcCtD
Ivacaftor—Diarrhoea—Prednisone—prostate cancer	6.62e-05	0.000444	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Epirubicin—prostate cancer	6.53e-05	0.000438	CcSEcCtD
Ivacaftor—Nausea—Capecitabine—prostate cancer	6.45e-05	0.000432	CcSEcCtD
Ivacaftor—Dizziness—Prednisone—prostate cancer	6.4e-05	0.000429	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Doxorubicin—prostate cancer	6.38e-05	0.000428	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Epirubicin—prostate cancer	6.19e-05	0.000415	CcSEcCtD
Ivacaftor—Rash—Prednisone—prostate cancer	6.1e-05	0.000409	CcSEcCtD
Ivacaftor—Dermatitis—Prednisone—prostate cancer	6.09e-05	0.000408	CcSEcCtD
Ivacaftor—Headache—Prednisone—prostate cancer	6.06e-05	0.000406	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Doxorubicin—prostate cancer	6.04e-05	0.000405	CcSEcCtD
Ivacaftor—Abdominal pain—Epirubicin—prostate cancer	5.98e-05	0.000401	CcSEcCtD
Ivacaftor—Nausea—Prednisone—prostate cancer	5.75e-05	0.000385	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Doxorubicin—prostate cancer	5.72e-05	0.000384	CcSEcCtD
Ivacaftor—Abdominal pain—Doxorubicin—prostate cancer	5.53e-05	0.000371	CcSEcCtD
Ivacaftor—Diarrhoea—Epirubicin—prostate cancer	5.18e-05	0.000347	CcSEcCtD
Ivacaftor—Dizziness—Epirubicin—prostate cancer	5e-05	0.000335	CcSEcCtD
Ivacaftor—Diarrhoea—Doxorubicin—prostate cancer	4.79e-05	0.000321	CcSEcCtD
Ivacaftor—Rash—Epirubicin—prostate cancer	4.77e-05	0.00032	CcSEcCtD
Ivacaftor—Dermatitis—Epirubicin—prostate cancer	4.77e-05	0.000319	CcSEcCtD
Ivacaftor—Headache—Epirubicin—prostate cancer	4.74e-05	0.000318	CcSEcCtD
Ivacaftor—Dizziness—Doxorubicin—prostate cancer	4.63e-05	0.00031	CcSEcCtD
Ivacaftor—Nausea—Epirubicin—prostate cancer	4.49e-05	0.000301	CcSEcCtD
Ivacaftor—Rash—Doxorubicin—prostate cancer	4.41e-05	0.000296	CcSEcCtD
Ivacaftor—Dermatitis—Doxorubicin—prostate cancer	4.41e-05	0.000296	CcSEcCtD
Ivacaftor—Headache—Doxorubicin—prostate cancer	4.39e-05	0.000294	CcSEcCtD
Ivacaftor—Nausea—Doxorubicin—prostate cancer	4.16e-05	0.000279	CcSEcCtD
Ivacaftor—ALB—Metabolism—ABCG5—prostate cancer	1.07e-05	0.000223	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—SULT1A1—prostate cancer	1.07e-05	0.000223	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—prostate cancer	1.06e-05	0.000222	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—PDHA1—prostate cancer	1.06e-05	0.000222	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—UCP3—prostate cancer	1.06e-05	0.000222	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—GSTA3—prostate cancer	1.06e-05	0.000222	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—TCN2—prostate cancer	1.06e-05	0.000222	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—PLAU—prostate cancer	1.05e-05	0.000219	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—GSTA1—prostate cancer	1.04e-05	0.000218	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—HSD3B2—prostate cancer	1.03e-05	0.000215	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—NAT2—prostate cancer	1.03e-05	0.000215	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—GSTO1—prostate cancer	1.03e-05	0.000215	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—CAV1—prostate cancer	1.02e-05	0.000214	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—AMACR—prostate cancer	1.01e-05	0.000212	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—CYP3A43—prostate cancer	1.01e-05	0.000212	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—NAT1—prostate cancer	1.01e-05	0.000212	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—DEGS1—prostate cancer	1.01e-05	0.000212	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—SRD5A2—prostate cancer	1.01e-05	0.000212	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—HSD3B1—prostate cancer	1.01e-05	0.000212	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—SLC22A3—prostate cancer	1.01e-05	0.000212	CbGpPWpGaD
Ivacaftor—ALB—Platelet activation, signaling and aggregation—TGFB1—prostate cancer	9.91e-06	0.000207	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	9.89e-06	0.000207	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—CYP2C18—prostate cancer	9.86e-06	0.000206	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—LRP2—prostate cancer	9.86e-06	0.000206	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—PLCB2—prostate cancer	9.86e-06	0.000206	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	9.78e-06	0.000205	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	9.76e-06	0.000204	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—GSTA4—prostate cancer	9.7e-06	0.000203	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—TBXAS1—prostate cancer	9.7e-06	0.000203	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—P4HB—prostate cancer	9.67e-06	0.000202	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—HSD17B1—prostate cancer	9.67e-06	0.000202	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	9.57e-06	0.0002	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—GSTA2—prostate cancer	9.45e-06	0.000198	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—SLC22A1—prostate cancer	9.41e-06	0.000197	CbGpPWpGaD
Ivacaftor—ALB—Transmembrane transport of small molecules—PPARA—prostate cancer	9.41e-06	0.000197	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—SULT1A1—prostate cancer	9.33e-06	0.000195	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—ABCG5—prostate cancer	9.33e-06	0.000195	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—PIK3CG—prostate cancer	9.31e-06	0.000195	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	9.3e-06	0.000195	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—EGF—prostate cancer	9.2e-06	0.000192	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—SULT2A1—prostate cancer	9.17e-06	0.000192	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—GSTA1—prostate cancer	9.12e-06	0.000191	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	9.04e-06	0.000189	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—MED12—prostate cancer	9.02e-06	0.000189	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—GSTO1—prostate cancer	9.02e-06	0.000189	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—HSD3B2—prostate cancer	9.02e-06	0.000189	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—NAT2—prostate cancer	9.02e-06	0.000189	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—GNG5—prostate cancer	8.95e-06	0.000187	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—PLCB2—prostate cancer	8.64e-06	0.000181	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—CYP2C18—prostate cancer	8.64e-06	0.000181	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—LRP2—prostate cancer	8.64e-06	0.000181	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—CREBBP—prostate cancer	8.63e-06	0.00018	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—NCOA3—prostate cancer	8.62e-06	0.00018	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—HPGD—prostate cancer	8.62e-06	0.00018	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—B4GALT4—prostate cancer	8.62e-06	0.00018	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—IGF1—prostate cancer	8.52e-06	0.000178	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—P4HB—prostate cancer	8.48e-06	0.000177	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	8.47e-06	0.000177	CbGpPWpGaD
Ivacaftor—ALB—Platelet activation, signaling and aggregation—PIK3CA—prostate cancer	8.43e-06	0.000176	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	8.3e-06	0.000174	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—SLC22A1—prostate cancer	8.25e-06	0.000172	CbGpPWpGaD
Ivacaftor—ABCB1—Transmembrane transport of small molecules—PPARA—prostate cancer	8.24e-06	0.000172	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—HPGDS—prostate cancer	8.23e-06	0.000172	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—PIK3CD—prostate cancer	8.18e-06	0.000171	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—CYP2C19—prostate cancer	8.17e-06	0.000171	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—TNFRSF21—prostate cancer	8.1e-06	0.000169	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—SERPINE1—prostate cancer	8.09e-06	0.000169	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—SULT2A1—prostate cancer	8.04e-06	0.000168	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	8.03e-06	0.000168	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—GSTT1—prostate cancer	7.98e-06	0.000167	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—ACHE—prostate cancer	7.98e-06	0.000167	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—MED12—prostate cancer	7.91e-06	0.000165	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—CYP2A6—prostate cancer	7.89e-06	0.000165	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—MTAP—prostate cancer	7.88e-06	0.000165	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—CYP7B1—prostate cancer	7.88e-06	0.000165	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	7.86e-06	0.000164	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—GNG5—prostate cancer	7.84e-06	0.000164	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—NOS3—prostate cancer	7.73e-06	0.000162	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—SULT1E1—prostate cancer	7.68e-06	0.000161	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—SRD5A1—prostate cancer	7.68e-06	0.000161	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—AKR1C3—prostate cancer	7.67e-06	0.00016	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—PRKACB—prostate cancer	7.63e-06	0.00016	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—NCOA3—prostate cancer	7.56e-06	0.000158	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—CYP17A1—prostate cancer	7.55e-06	0.000158	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—JAK2—prostate cancer	7.51e-06	0.000157	CbGpPWpGaD
Ivacaftor—ALB—Transmembrane transport of small molecules—CREBBP—prostate cancer	7.47e-06	0.000156	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	7.45e-06	0.000156	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—HSD17B3—prostate cancer	7.33e-06	0.000153	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—ACSL4—prostate cancer	7.33e-06	0.000153	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—HPGDS—prostate cancer	7.21e-06	0.000151	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—NCOA2—prostate cancer	7.2e-06	0.000151	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—CYP2C19—prostate cancer	7.16e-06	0.00015	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—PIK3CB—prostate cancer	7.13e-06	0.000149	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—PHGDH—prostate cancer	7.03e-06	0.000147	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—UMPS—prostate cancer	7.03e-06	0.000147	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—ARG2—prostate cancer	7.03e-06	0.000147	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—ACHE—prostate cancer	6.99e-06	0.000146	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—GSTT1—prostate cancer	6.99e-06	0.000146	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—CYP2A6—prostate cancer	6.91e-06	0.000145	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—LDHB—prostate cancer	6.89e-06	0.000144	CbGpPWpGaD
Ivacaftor—ALB—Platelet activation, signaling and aggregation—AKT1—prostate cancer	6.89e-06	0.000144	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—SLC5A5—prostate cancer	6.87e-06	0.000144	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	6.78e-06	0.000142	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—CYP3A5—prostate cancer	6.76e-06	0.000141	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—AKR1C3—prostate cancer	6.72e-06	0.000141	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—CYP2E1—prostate cancer	6.71e-06	0.00014	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—PRKACB—prostate cancer	6.69e-06	0.00014	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—NQO1—prostate cancer	6.63e-06	0.000139	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—CYP17A1—prostate cancer	6.62e-06	0.000138	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—IL2—prostate cancer	6.55e-06	0.000137	CbGpPWpGaD
Ivacaftor—ABCB1—Transmembrane transport of small molecules—CREBBP—prostate cancer	6.54e-06	0.000137	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—TH—prostate cancer	6.53e-06	0.000137	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—PDHA1—prostate cancer	6.53e-06	0.000137	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—UCP3—prostate cancer	6.53e-06	0.000137	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—GSTA3—prostate cancer	6.53e-06	0.000137	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—TCN2—prostate cancer	6.53e-06	0.000137	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	6.49e-06	0.000136	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—CYP3A4—prostate cancer	6.47e-06	0.000135	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	6.43e-06	0.000135	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—CYP1B1—prostate cancer	6.36e-06	0.000133	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—NCOA2—prostate cancer	6.31e-06	0.000132	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—SLC22A3—prostate cancer	6.23e-06	0.00013	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—HSD3B1—prostate cancer	6.23e-06	0.00013	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—GGT1—prostate cancer	6.16e-06	0.000129	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—NCOA1—prostate cancer	6.06e-06	0.000127	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—SLC5A5—prostate cancer	6.02e-06	0.000126	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—CYP19A1—prostate cancer	5.98e-06	0.000125	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—GSTA4—prostate cancer	5.97e-06	0.000125	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—TBXAS1—prostate cancer	5.97e-06	0.000125	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—EP300—prostate cancer	5.88e-06	0.000123	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—CYP2E1—prostate cancer	5.88e-06	0.000123	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—GSTA2—prostate cancer	5.82e-06	0.000122	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—NQO1—prostate cancer	5.81e-06	0.000121	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—RXRA—prostate cancer	5.77e-06	0.000121	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—ABCG5—prostate cancer	5.75e-06	0.00012	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—SULT1A1—prostate cancer	5.75e-06	0.00012	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—TH—prostate cancer	5.73e-06	0.00012	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—SRC—prostate cancer	5.71e-06	0.00012	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—CYP3A4—prostate cancer	5.67e-06	0.000118	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—GSTA1—prostate cancer	5.62e-06	0.000117	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	5.61e-06	0.000117	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—CYP1B1—prostate cancer	5.57e-06	0.000116	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—VEGFA—prostate cancer	5.57e-06	0.000116	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—COMT—prostate cancer	5.56e-06	0.000116	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—NAT2—prostate cancer	5.55e-06	0.000116	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—HSD3B2—prostate cancer	5.55e-06	0.000116	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—GSTO1—prostate cancer	5.55e-06	0.000116	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—GSTP1—prostate cancer	5.53e-06	0.000116	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—ITPR1—prostate cancer	5.44e-06	0.000114	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—GGT1—prostate cancer	5.39e-06	0.000113	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—EP300—prostate cancer	5.35e-06	0.000112	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—LRP2—prostate cancer	5.33e-06	0.000111	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—PLCB2—prostate cancer	5.33e-06	0.000111	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—CYP2C18—prostate cancer	5.33e-06	0.000111	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—NCOA1—prostate cancer	5.31e-06	0.000111	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—CYP19A1—prostate cancer	5.24e-06	0.00011	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—P4HB—prostate cancer	5.22e-06	0.000109	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—TYMS—prostate cancer	5.14e-06	0.000108	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—TGFB1—prostate cancer	5.11e-06	0.000107	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—GSTM1—prostate cancer	5.08e-06	0.000106	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—SLC22A1—prostate cancer	5.08e-06	0.000106	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—RXRA—prostate cancer	5.05e-06	0.000106	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—LPL—prostate cancer	4.99e-06	0.000104	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—SULT2A1—prostate cancer	4.95e-06	0.000104	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—MED12—prostate cancer	4.87e-06	0.000102	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—COMT—prostate cancer	4.87e-06	0.000102	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—GSTP1—prostate cancer	4.85e-06	0.000101	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—GNG5—prostate cancer	4.83e-06	0.000101	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—CYP1A1—prostate cancer	4.82e-06	0.000101	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—ERCC2—prostate cancer	4.78e-06	9.99e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—ITPR1—prostate cancer	4.77e-06	9.97e-05	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—KRAS—prostate cancer	4.73e-06	9.9e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—NCOA3—prostate cancer	4.65e-06	9.73e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—TYMS—prostate cancer	4.5e-06	9.42e-05	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—MTHFR—prostate cancer	4.49e-06	9.39e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—GSTM1—prostate cancer	4.45e-06	9.31e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—HPGDS—prostate cancer	4.44e-06	9.29e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—CYP2C19—prostate cancer	4.41e-06	9.23e-05	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—PPARA—prostate cancer	4.41e-06	9.22e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—LPL—prostate cancer	4.37e-06	9.14e-05	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—PIK3CA—prostate cancer	4.35e-06	9.09e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—GSTT1—prostate cancer	4.31e-06	9.01e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—ACHE—prostate cancer	4.31e-06	9.01e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—CYP2A6—prostate cancer	4.26e-06	8.9e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—CYP1A1—prostate cancer	4.22e-06	8.83e-05	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—TP53—prostate cancer	4.21e-06	8.8e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—ERCC2—prostate cancer	4.19e-06	8.76e-05	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—CAV1—prostate cancer	4.14e-06	8.66e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—AKR1C3—prostate cancer	4.14e-06	8.66e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—PRKACB—prostate cancer	4.12e-06	8.62e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—CYP17A1—prostate cancer	4.08e-06	8.53e-05	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.96e-06	8.28e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—MTHFR—prostate cancer	3.94e-06	8.23e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—NCOA2—prostate cancer	3.88e-06	8.12e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—PPARA—prostate cancer	3.86e-06	8.07e-05	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—PIK3CG—prostate cancer	3.77e-06	7.89e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—SLC5A5—prostate cancer	3.71e-06	7.75e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—CAV1—prostate cancer	3.63e-06	7.59e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—CYP2E1—prostate cancer	3.62e-06	7.57e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—NQO1—prostate cancer	3.58e-06	7.49e-05	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—INS—prostate cancer	3.57e-06	7.47e-05	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—AKT1—prostate cancer	3.55e-06	7.43e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—TH—prostate cancer	3.53e-06	7.38e-05	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—CREBBP—prostate cancer	3.5e-06	7.32e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—CYP1B1—prostate cancer	3.43e-06	7.18e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—GGT1—prostate cancer	3.32e-06	6.95e-05	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—PIK3CD—prostate cancer	3.32e-06	6.94e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—PIK3CG—prostate cancer	3.31e-06	6.91e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—NCOA1—prostate cancer	3.27e-06	6.85e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—CYP19A1—prostate cancer	3.23e-06	6.75e-05	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—NOS3—prostate cancer	3.13e-06	6.55e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—INS—prostate cancer	3.13e-06	6.55e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—RXRA—prostate cancer	3.11e-06	6.51e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—CREBBP—prostate cancer	3.07e-06	6.41e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—COMT—prostate cancer	3e-06	6.27e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—GSTP1—prostate cancer	2.99e-06	6.24e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—ITPR1—prostate cancer	2.94e-06	6.14e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—PIK3CD—prostate cancer	2.91e-06	6.08e-05	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—PIK3CB—prostate cancer	2.89e-06	6.05e-05	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—PTGS2—prostate cancer	2.86e-06	5.99e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—TYMS—prostate cancer	2.78e-06	5.8e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—NOS3—prostate cancer	2.74e-06	5.74e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—GSTM1—prostate cancer	2.74e-06	5.74e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—LPL—prostate cancer	2.69e-06	5.63e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—CYP1A1—prostate cancer	2.6e-06	5.44e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—ERCC2—prostate cancer	2.58e-06	5.39e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—PIK3CB—prostate cancer	2.53e-06	5.3e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—PTGS2—prostate cancer	2.51e-06	5.25e-05	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—PTEN—prostate cancer	2.5e-06	5.23e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—MTHFR—prostate cancer	2.42e-06	5.07e-05	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—EP300—prostate cancer	2.38e-06	4.98e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—PPARA—prostate cancer	2.38e-06	4.97e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—CAV1—prostate cancer	2.24e-06	4.68e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—PTEN—prostate cancer	2.19e-06	4.58e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—EP300—prostate cancer	2.09e-06	4.37e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—PIK3CG—prostate cancer	2.04e-06	4.26e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—INS—prostate cancer	1.93e-06	4.03e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—CREBBP—prostate cancer	1.89e-06	3.95e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.79e-06	3.75e-05	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—PIK3CA—prostate cancer	1.76e-06	3.69e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—NOS3—prostate cancer	1.69e-06	3.54e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.56e-06	3.26e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—PTGS2—prostate cancer	1.55e-06	3.23e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—PIK3CA—prostate cancer	1.54e-06	3.23e-05	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—AKT1—prostate cancer	1.44e-06	3.01e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—PTEN—prostate cancer	1.35e-06	2.82e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—EP300—prostate cancer	1.29e-06	2.69e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—AKT1—prostate cancer	1.26e-06	2.64e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—PIK3CA—prostate cancer	9.52e-07	1.99e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—AKT1—prostate cancer	7.77e-07	1.63e-05	CbGpPWpGaD
